Tech Company Inital Public Offerings

PhaseBio Pharmaceuticals IPO

Headquartered in Malvern, PhaseBio Pharmaceuticals is now a public company.

Transaction Overview

Announced On
Transaction Type
Proceeds Purpose
Proceeds will be used as follows: approximately $37.0 million to $39.0 million to advance PB2452; approximately $11.0 million to $13.0 million to advance PB1046; approximately $12.0 million to $14.0 million to fund development of our ELP technology and preclinical programs; and the remainder for working capital and other general corporate purposes.

Company Information

Company Status
Mailing Address
1 Great Valley Pkwy. 30
Malvern, PA 19355
Email Address
Not Recorded
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), located in Malvern, PA, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals.
PhaseBio Pharmaceuticals LinkedIn Company Profile
Social Media
PhaseBio Pharmaceuticals Company Twitter Account
Company News
PhaseBio Pharmaceuticals News
PhaseBio Pharmaceuticals on Facebook
PhaseBio Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Jonathan Mow
  Jonathan Mow LinkedIn Profile  Jonathan Mow Twitter Account  Jonathan Mow News  Jonathan Mow on Facebook
Chief Financial Officer
John Sharp
  John Sharp LinkedIn Profile  John Sharp Twitter Account  John Sharp News  John Sharp on Facebook
Chief Medical Officer
John Lee
  John Lee LinkedIn Profile  John Lee Twitter Account  John Lee News  John Lee on Facebook
VP - Bus. Development
Susan Arnold
  Susan Arnold LinkedIn Profile  Susan Arnold Twitter Account  Susan Arnold News  Susan Arnold on Facebook
VP - Bus. Development
Michael York
  Michael York LinkedIn Profile  Michael York Twitter Account  Michael York News  Michael York on Facebook
VP - R & D
James Ballance
  James Ballance LinkedIn Profile  James Ballance Twitter Account  James Ballance News  James Ballance on Facebook



Browse more venture capital transactions:

Prev: 10/17/2018: Hubb venture capital transaction
Next: 10/17/2018: Velicept Therapeutics venture capital transaction


Share this article


About Database of VC Transactions

We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary